Head and Neck Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed through laboratory testing with a specific type of throat cancer (squamous cell carcinoma or a related variant) located in the voice box (glottis).
- People whose cancer is classified as stage 0, I, or II (meaning it has not spread beyond the voice box), confirmed by a camera examination of the throat and imaging scans showing no signs of cancer in nearby lymph nodes.
- People who are 18 years of age or older.
- People who are generally able to carry out daily activities, with only mild limitations at most (this is measured on a standard medical scale — confirm with trial site).
- Women who could potentially become pregnant, and men, must be willing to use reliable contraception during the trial and for 90 days after treatment ends. This applies to women who have not had their uterus or both ovaries removed, and who have had a menstrual period at any point in the past 12 months.
- People who are able to understand the study information and are willing to sign a consent form.
Who may not be able to join:
- People whose larynx cancer is classified as stage III or stage IV.
- People whose cancer has spread to a specific part of the voice box cartilage beyond a defined boundary (confirm with trial site).
- People who have previously received chemotherapy to treat this particular throat cancer.
- People who have another separate cancer present at the same time in the head or neck area.
- People who have previously had radiation therapy in the same area of the body in a way that would overlap with the radiation planned in this trial.
- People who currently smoke more than one pack of cigarettes per day.
- People who are currently taking part in another clinical trial involving an experimental treatment.
- People with serious uncontrolled health conditions, such as an active infection, uncontrolled heart failure, unstable chest pain, irregular heart rhythm, or a mental health or personal situation that may make it difficult to follow the trial requirements.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: David Sher, MD, MPH, University of Texas Southwestern Medical Center
Phone: 214-645-2465
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To compare the acute toxicity outcomes between patients treated with highly-conformal hypofractionated radiotherapy and conventional radiotherapy.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.